143 related articles for article (PubMed ID: 30909848)
21. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
[TBL] [Abstract][Full Text] [Related]
22. Osteosarcoma and Ewing's sarcoma in children and adolescents: retrospective clinicopathological study.
Ilić I; Manojlović S; Cepulić M; Orlić D; Seiwerth S
Croat Med J; 2004 Dec; 45(6):740-5. PubMed ID: 15578809
[TBL] [Abstract][Full Text] [Related]
23. Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution Experience.
Berlanga P; Cañete A; Díaz R; Salom M; Baixauli F; Gómez J; Llavador M; Castel V
J Pediatr Hematol Oncol; 2015 Jul; 37(5):e272-7. PubMed ID: 25374283
[TBL] [Abstract][Full Text] [Related]
24. Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma.
Hu K; Wang Z; Lin P; Wen Z; Ren H; Sun L; Li H; Li B; Wang S; Zhou X; Tengwang S; Xu L; Ye Z
Oncotarget; 2017 Jun; 8(26):43130-43139. PubMed ID: 28562345
[TBL] [Abstract][Full Text] [Related]
25. Relationship between red cell distribution width and prognosis of patients with osteosarcoma.
Zheng J; Yuan X; Guo W
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31815279
[TBL] [Abstract][Full Text] [Related]
26. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
27. Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy.
Costello F; Zimmerman MB; Podhajsky PA; Hayreh SS
Eur J Ophthalmol; 2004; 14(3):245-57. PubMed ID: 15206651
[TBL] [Abstract][Full Text] [Related]
28. Vitronectin significantly influences prognosis in osteosarcoma.
Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
[TBL] [Abstract][Full Text] [Related]
29. Cytologic anaplasia is a prognostic factor in osteosarcoma biopsies, but mitotic rate or extent of spontaneous tumor necrosis are not: a critique of the College of American Pathologists Bone Biopsy template.
Cates JM; Dupont WD
Mod Pathol; 2017 Jan; 30(1):52-59. PubMed ID: 27658478
[TBL] [Abstract][Full Text] [Related]
30. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
Zhu Y; Zhou J; Ji Y; Yu B
Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
[TBL] [Abstract][Full Text] [Related]
31. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
[TBL] [Abstract][Full Text] [Related]
32. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
[TBL] [Abstract][Full Text] [Related]
33. Effect of perioperative transfusions on survival in osteosarcoma treated by multimodal therapy.
Chesi R; Cazzola A; Bacci G; Borghi B; Balladelli A; Urso G
Cancer; 1989 Oct; 64(8):1727-37. PubMed ID: 2790686
[TBL] [Abstract][Full Text] [Related]
34. A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG.
Flores RJ; Kelly AJ; Li Y; Nakka M; Barkauskas DA; Krailo M; Wang LL; Perlaky L; Lau CC; Hicks MJ; Man TK
Cancer; 2017 Jan; 123(1):144-154. PubMed ID: 27529817
[TBL] [Abstract][Full Text] [Related]
35. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
Gu R; Sun Y
J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer].
Bień E; Balcerska A
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1081-9. PubMed ID: 15951603
[TBL] [Abstract][Full Text] [Related]
37. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
[TBL] [Abstract][Full Text] [Related]
38. ESR or CRP? A comparison of their clinical utility.
Osei-Bimpong A; Meek JH; Lewis SM
Hematology; 2007 Aug; 12(4):353-7. PubMed ID: 17654065
[TBL] [Abstract][Full Text] [Related]
39. [Diagnostic value of C-reactive protein in comparison with erythrocyte sedimentation as routine admission diagnostic test].
Buess T; Ludwig C
Schweiz Med Wochenschr; 1995 Jan; 125(4):120-4. PubMed ID: 7878400
[TBL] [Abstract][Full Text] [Related]
40. The Diagnostic and Prognostic Value of Hematological and Chemical Abnormalities in Soft Tissue Sarcoma: A Comparative Study in Patients with Benign and Malignant Soft Tissue Tumors.
Ariizumi T; Kawashima H; Ogose A; Sasaki T; Hotta T; Hatano H; Morita T; Endo N
Ann Clin Lab Sci; 2018 Jan; 48(1):11-17. PubMed ID: 29530991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
